CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-05 | Lewis Tanya EVP, Chief Reg. Affairs | Exercise or conversion | +5,650 | 6,189 | ||
| 2021-02-05 | Lewis Tanya EVP, Chief Reg. Affairs | Exercise or conversion · Restricted Stock Units | −5,650 | 16,950 | ||
| 2021-02-05 | Frenkel Ran EVP, Chief Dev. Officer | Exercise or conversion | +5,650 | 41,384 | ||
| 2021-02-05 | Frenkel Ran EVP, Chief Dev. Officer | Exercise or conversion · Restricted Stock Units | −5,650 | 16,950 | ||
| 2021-02-05 | Mason Michael SVP, CFO & Treasurer | Exercise or conversion | +8,150 | 8,150 | ||
| 2021-02-05 | Mason Michael SVP, CFO & Treasurer | Exercise or conversion · Restricted Stock Units | −8,150 | 24,450 | ||
| 2021-02-05 | Shacham Sharon President & CSO | Exercise or conversion | +14,300 | 770,789 | ||
| 2021-02-05 | Shacham Sharon President & CSO | Exercise or conversion | +14,300 | 569,422 | ||
| 2021-02-05 | Shacham Sharon President & CSO | Exercise or conversion · Restricted Stock Units | −14,300 | 42,900 | ||
| 2021-02-05 | Shacham Sharon President & CSO | Exercise or conversion · Restricted Stock Units | −14,300 | 42,900 | ||
| 2021-02-05 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +14,300 | 569,422 | ||
| 2021-02-05 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +14,300 | 770,789 | ||
| 2021-02-05 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −14,300 | 42,900 | ||
| 2021-02-05 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Restricted Stock Units | −14,300 | 42,900 | ||
| 2020-12-18 | Mirza Mansoor Raza Director | Exercise or conversion | +5,000 | $5.43 | $27K | 5,000 |
| 2020-12-18 | Mirza Mansoor Raza Director | Sale | −5,000 | $18.00 | $90K | 0 |
| 2020-12-18 | Mirza Mansoor Raza Director | Exercise or conversion · Stock Option (right to buy) | −5,000 | 0 | ||
| 2020-12-07 | Mirza Mansoor Raza Director | Exercise or conversion | +20,000 | $5.43 | $109K | 20,000 |
| 2020-12-07 | Mirza Mansoor Raza Director | Sale | −5,000 | $16.05 | $80K | 15,000 |
| 2020-12-07 | Mirza Mansoor Raza Director | Sale | −5,000 | $16.05 | $80K | 10,000 |
Page 19 of 29 · 570 trades